Insider Transactions in Q2 2025 at Generation Bio Co. (GBIO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 15
2025
|
Kevin John Conway Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-0.96%
|
$0
$0.37 P/Share
|
|
Apr 15
2025
|
Kevin John Conway Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
587
+3.15%
|
-
|
|
Apr 15
2025
|
Yalonda Howze CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
983
-4.98%
|
$0
$0.37 P/Share
|
|
Apr 15
2025
|
Yalonda Howze CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,347
+14.51%
|
-
|
|
Apr 15
2025
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
468
-1.99%
|
$0
$0.37 P/Share
|
|
Apr 15
2025
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,592
+6.33%
|
-
|
|
Apr 15
2025
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,548
-0.11%
|
$0
$0.37 P/Share
|
|
Apr 15
2025
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,274
+0.39%
|
-
|
|
Apr 15
2025
|
Phillip Samayoa CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
337
-0.26%
|
$0
$0.37 P/Share
|
|
Apr 15
2025
|
Phillip Samayoa CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,147
+0.88%
|
-
|